Ultime notizie per Nvni Group (NASDAQ:NVNI) Azioni

Nvni Group

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

Nvni Group Ltd

<a href="https://www.bloomberg.com/news/articles/2025-07-28/albertsons-demands-details-on-ex-kroger-ceo-s-personal-conduct?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-28/albertsons-demands-details-on-ex-kroger-ceo-s-personal-conduct?embedded-checkout=true</a>

News

General

'Albertsons Demands Details on Ex-Kroger CEO's Personal Conduct'- Bloomberg

DA Davidson analyst Griffin Bryan maintains Brunswick (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BC#NYSE">BC</a>) with a Neutral and raises the price target from $43 to $59.

Price Target

Analyst Ratings

DA Davidson Maintains Neutral on Brunswick, Raises Price Target to $59

ARGT

Reuters Reports Grain Chambers Saying Argentina To Resume Soy Exports Once Tax Cut Official

Coffee chain Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) could show more signs of a turnaround — or hints that competition is gaining market share — when the company reports third-quarter financial results Tuesday after market close.
Check out Starbucks&#8217; stock <a href="https://www.benzinga.com/quote/SBUX">current price here</a>.
Here are the earnings estimates, what analysts are saying and key items to watch.
Earnings Estimates: Analysts expect Starbucks to report third-quarter revenue of $9.29 billion, up from $9.11 billion in last year's third quarter, according to data from Benzinga Pro.
The company missed analyst estimates for revenue last quarter and missed estimates in seven of the past 10 quarters.
Analysts expect the company to post third-quarter earnings per share of 65 cents, down from 93 cents per share in last year's third quarter. The company missed analyst estimates last quarter and has missed estimates for earnings per share in five of the past 10 quarters.
What Analysts Are Saying: Starbucks rolling out the Green Apron staffing model in the U.S. could be a headwind to 2026 and 2027 earnings, TD Cowen analyst Andrew Charles said ahead of the earnings report.
The analyst maintained a Hold rating and price target of $90.
Charles said the Green Apron model could increase labor costs for Starbucks by 12% at its U.S. stores, with the rollout of the assistant store manager position at all U.S. company-owned stores adding to the headwinds in 2026.
While the model could increase labor costs, Charles also highlights the potential positive impact on sales. The analyst raised same-store sales estimates for 2026 through 2028 as a result.
See Also: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46053495/starbucks-green-apron-expansion-to-boost-service-but-squeeze-earnings-through-2027">Starbucks&#8217; Green Apron Expansion To Boost Service — But Squeeze Earnings Through 2027</a>
Here are other recent analyst ratings on Starbucks and their price targets:
<ul class="wp-block-list">
<li>Bank of America: Maintained Buy rating, raised price target from $101 to $110</li>
<li>Barclays: Maintained Overweight rating, lowered price target from $108 to $106</li>
<li>Jefferies: Downgraded from Hold to Underperform rating with price target of $76</li>
<li>Citigroup: Maintained Neutral rating, raised price target from $95 to $100</li>
<li>Stifel: Maintained Buy rating, raised price target from $92 to $105</li>
</ul>
Key Items to Watch: A Placer.ai report highlights that Starbucks has had a consistent number of unique visitors in recent years. Overall visits have declined in recent months, but 2025 is also showing signs of a recovery from late 2024, according to the report.
The Placer.ai report shows January monthly visits up 3.1% and April visits up 0.9% on a year-over-year basis. The other months saw declines, but the year-over-year drops of 1.7% in March and 0.7% in May were less than late 2024.
The last four months of 2024 saw monthly visit declines of 6.0%, 4.7%, 1.6% and 2.9% for September through December, respectively.
Starbucks is putting an emphasis on loyal visits with its menu and moving away from short-term discounts, the report highlights. This strategy could take time, but the early results show that it could already be paying off based on monthly visits.
Placer.ai points to competition for Starbucks that includes drive-thru coffee chains, coffee houses and some consumers brewing their own coffee at home.
Investors and analysts will be looking to see if Starbucks highlights its strong loyal consumer base during the results and if any comments on trends for competition are shared.
The company's second quarter saw comparable store sales down 1% in North America, down 2% internationally and flat in China.
With new CEO Brian Niccol, Starbucks is undergoing transformations with plans like "Back to Starbucks" and "Green Apron."
Analysts remain cautious on the outcome of the plans and what impact they will have on 2025 and 2026 results.
Starbucks has been quiet on guidance since Niccol took over. Guidance for the rest of the fiscal year could create more volatility for shares after the earnings report.
SBUX Price Action: Starbucks stock is down 0.85% to $93.62 on Monday versus a 52-week trading range of $72.72 to $117.46. Starbucks stock is up 2.2% year-to-date in 2025. Read Next: •<a href="https://www.benzinga.com/markets/equities/25/07/46667345/wall-street-today-stocks-monday-us-eu-trade-deal-oil-energy"> Oil, Energy Stocks Rise, Dollar Rallies On US-EU Trade Deal: What&#8217;s Moving Markets Monday?</a>
Photo: Ned Snowman via Shutterstock

Analyst Color

Earnings

Previews

Restaurants

Trading Ideas

SBUX

Starbucks Q3 Preview: Report Could Show Consumers Ditching Lattes For Living Rooms — Or Sipping Elsewhere

DA Davidson analyst Brent Thielman maintains Comfort Systems USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) with a Buy and raises the price target from $630 to $810.

DA Davidson Maintains Buy on Comfort Systems USA, Raises Price Target to $810

<a href="https://www.benzinga.com/topic/memecoins">Meme coins</a> represent a maturing crypto market, enabling users to rally behind narratives and launch tokens from scratch, according to Cindy Leow, co-founder of Drift Protocol, a Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)-based decentralized exchange (DEX).
In an interview with Benzinga, Leow highlighted the sustained relevance of meme coins, noting their role in showcasing the ability to create and trade tokens organically, despite recent market slowdowns. 
She emphasized that meme coin cycles within broader market cycles signal a growing sophistication in decentralized finance.
Leow discussed Drift's significant growth, with on-chain perpetual futures (perps) volume increasing fivefold in the past three weeks, driven by improved user experience (UX) and liquidity. 
She noted that past hurdles to on-chain perps adoption, such as onboarding and UX issues, have largely been resolved, making trading on DEXs comparable to centralized exchanges (CEXs). 
"The experience of trading on-chain is a lot better now than even a couple of months ago," Leow said, underscoring Drift's advancements in matching CEX performance.
A key factor in Drift's success is its commitment to Solana's Layer 1 (L1) blockchain, which Leow praised for its trustless and verifiable nature, ensuring funds remain secure and accessible. 
"Censorship resistance is one of the biggest things," she said, emphasizing the reliability of L1s over CEXs, which can be shut down abruptly. 
Drift's Just-In-Time (JIT) liquidity model, an intent-based protocol, enhances trading efficiency by allowing market makers to fill orders directly, bypassing gas costs and improving matching speed.
Leow also addressed the role of meme coins in driving perps volume on DEXs, describing them as a sustainable trend. 
"There will always be room for meme coins because it shows that people have an ability to rally behind a narrative," she said. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46663393/paypal-rolls-out-new-crypto-feature-heres-why-you-should-care">PayPal Rolls Out New Crypto Feature: Here&#8217;s Why You Should Care</a>
However, she acknowledged a recent dip in meme coin performance, attributing it to market maturation rather than a decline in interest.
On real-world hedging, Leow argued that on-chain derivatives are already facilitating significant hedging activity. 
Drift's cross-margin system allows users to leverage assets like SOL or USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) as collateral to hedge positions, such as shorting SOL perps to maintain neutral exposure.
She predicted growth in basis trading as more hedgers enter DeFi.
Regarding competition, Leow favored generalized L1s like Solana over app-specific chains like dYdX (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">DYDX</a>) on Cosmos (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/atom/usd">ATOM</a>), citing Solana's upcoming Block Assembly Marketplace (BAM) for enabling app-chain customizability within an L1. 
She also noted challenges in expanding on-chain options trading due to its over-the-counter (OTC) nature but suggested intent-based protocols could drive future success.
Drift's focus on cross-collateralization, allowing any token as collateral, has boosted its total value locked (TVL) and trading volume, particularly in bull markets. 
Unlike competitors like Zeta Markets, which pivoted away from Solana, Leow said Drift's dedication to the ecosystem has ensured its longevity. 
She emphasized filtering for organic retail flow to maintain quality volume, avoiding toxic flows from excessive incentives.
Leow predicted that perps liquidity will consolidate around a few superchains with established infrastructure and liquidity, dismissing fragmented multi-chain models. 
"People will consolidate towards the chain that already has dollars, that has backers," she said.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46658075/sui-joins-bitcoin-ethereum-with-its-own-treasury-company-look-whos-building-a-450-million-reserve">SUI Joins Bitcoin, Ethereum With Its Own Treasury Company: Look Who&#8217;s Building A $450 Million Reserve</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ATOM

$DYDX

$SOL

$USDC

Meme Coins Reflect Crypto Market Maturation, Says Drift Protocol's Cindy Leow

DA Davidson analyst Manuel Navas maintains Burke &amp; Herbert Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHRB#NASDAQ">BHRB</a>) with a Buy and raises the price target from $69 to $73.

BHRB

DA Davidson Maintains Buy on Burke & Herbert Financial, Raises Price Target to $73

DA Davidson analyst Gary Tenner maintains Cadence Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CADE#NYSE">CADE</a>) with a Buy and raises the price target from $37 to $42.

CADE

DA Davidson Maintains Buy on Cadence Bank, Raises Price Target to $42

DA Davidson analyst Peter Winter maintains Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) with a Buy and raises the price target from $69 to $78.

CUBI

DA Davidson Maintains Buy on Customers Bancorp, Raises Price Target to $78

Michael Saylor's Strategy (MSTR) just bought another 4,980 BTC worth over $500 million, further solidifying its position as the <a href="https://www.coingecko.com/en/public-companies-bitcoin?utm_source=chatgpt.com">largest public company holder</a> of Bitcoin (BTC). It now commands 2.74% of the total Bitcoin supply, outpacing the second-largest holder, Marathon Digital, which owns 0.22%, by a country mile. 
But what's even more apparent from looking at the list of corporate Bitcoin holders isn't just the dominance of one key player – it's the fact that more than half of the 34 companies are US-based, and all but one of the top ten holders, Japan's Metaplanet, are U.S. corporations. 
Together, the 34 companies account for nearly 700,000 BTC, or 95.8% of the total amount of BTC held in corporate treasuries.&nbsp;
Bridging the access gap for institutions
While corporate Bitcoin treasuries may offer a hedge against fiat devaluation or market volatility, their most overlooked value is systemic: they unlock access to Bitcoin for a class of investors who are otherwise locked out. Many institutional investors – particularly pension funds, insurance companies, and mutual funds – are governed by mandates that prohibit them from buying crypto ETFs, offshore funds, or even Bitcoin itself.
But those same mandates do permit investment in domestic, listed equities. A publicly traded company that holds Bitcoin on its balance sheet and meets domestic listing requirements can be slotted directly into these portfolios without breaching mandate restrictions. So corporate Bitcoin treasuries don't just benefit the company holding the BTC. They serve as a compliant, regulatorily sanctioned access point for everyone else.
It may seem like a small cohort of investors, but in fact, many institutions and funds are constrained by strict mandates that currently put Bitcoin completely out of their reach. For example, <a href="https://www.rbcgam.com/documents/fund-pages/monthly/rbf269_e.pdf">more than 600</a> Canadian-equity mutual funds – the country's largest peer group – are legally barred from holding anything but domestic stocks.&nbsp;
Even Canada's Maple-Eight pension titans, which steward roughly $2.4 trillion in retirement savings, have <a href="https://www.benefitsandpensionsmonitor.com/investments/alternative-investments/are-canadian-pension-funds-warming-up-to-crypto/391613#:~:text=Despite%20their%20hesitancy%2C%20pension%20funds,rather%20than%20holding%20bitcoin%20itself.">zero direct Bitcoin exposure</a>. And even if they do hold crypto funds or ETFs, there are strict limits on exposure to these vehicles, which fall into the alternative asset bracket, typically between 1% and 5%. A domestic listed company share, on the other hand, would fit into the 90-100% domestic equity bracket.
Canada is just one example, but most countries place similar restrictions on their institutional investment firms and funds. And this is exactly where a locally listed company with Bitcoin on its balance sheet fills in the gap.&nbsp;
ETFs vs listed equities
That's not to say spot Bitcoin ETFs haven't been a game-changer for all types of investors – they have. Canada, the first to launch spot Bitcoin ETFs back in 2021, has seen total assets hit C$5 billion this year, while in the US, BlackRock's (BLK) spot BTC ETF has ballooned into a $70 billion behemoth. 
But ETFs are about ease of access and liquidity – corporate treasuries are about much more than that. Like any listed company, corporate Bitcoin treasuries have governance oversight, a long-term business strategy, and the potential for capital appreciation. Unlike an ETF, a company share can also be bought at a discount to NAV when market conditions permit, and, crucially, offers the opportunity to grow Bitcoin-per-share value over time – not just accumulate BTC holdings. Yes, you get operating-company risk – but you also gain audited disclosure, GAAP reporting, and optional upside from profit-funded BTC purchases.
So, while it may seem to some like an odd proposition to invest in Bitcoin via a locally listed vehicle, this is exactly what's required for certain investors to be able to gain exposure to the best-performing asset over the last five years.
A new safe haven
But these investors can't just buy Michael Saylor's Strategy – they need domestic investment vehicles. And, indeed, this is no bad thing, as having one Bitcoin treasury company dominate the market is reminiscent of a monopoly, while the prevalence of U.S. companies among existing Bitcoin treasuries risks skewing the Bitcoin market heavily in favor of one country. 
If Bitcoin treasuries truly want to open up access to Bitcoin to as many investors as possible, they have to follow the local rules. Until there is a strategy in every country, the Bitcoin investment gap for pension funds and other local institutional investors will remain, and they will unfairly get left behind in terms of returns.
Bitcoin is no longer a fringe asset with high volatility only fit for the brave investor – it is increasingly becoming a strategic must-have allocation. With the US dollar projected to keep plummeting by leading banks like Morgan Stanley and Citi, and other global currencies hit by devaluation and inflation, Bitcoin is emerging as a safe haven.&nbsp;
And all companies, no matter where they are in the world, should consider adding safe-haven assets to their treasury reserves.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.

Opinion

Nations Need Sovereign Bitcoin Treasury Vehicles

WIIM

ENTA

Enanta Pharmaceuticals shares are trading higher after HC Wainwright & Co. assumed a Buy rating on the stock and announced a price target of $20.

DA Davidson analyst Manuel Navas maintains Origin Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OBK#NYSE">OBK</a>) with a Buy and raises the price target from $41 to $45.

DA Davidson Maintains Buy on Origin Bancorp, Raises Price Target to $45

ALLR

Allarity Therapeutics shares are trading higher after Ascendiant Capital initiated coverage on the stock with a Buy rating and announced a price target of $9.

TLYS

Tilly's shares are trading higher after the company announced a new appointee for the president, CEO, and director roles.

GeneDx Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) is preparing to release its quarterly earnings on Tuesday, 2025-07-29. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect GeneDx Hldgs to report an earnings per share (EPS) of $0.10.
GeneDx Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.18, which was followed by a 6.78% drop in the share price the next day.
Here's a look at GeneDx Hldgs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.09</td>
<td>0.1</td>
<td>-0.21</td>
<td>-0.3</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.27</td>
<td>0.6</td>
<td>0.04</td>
<td>-0.1</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-7.000000000000001%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>9.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753725786_0.png" alt="eps graph" />
<h3>Tracking GeneDx Hldgs's Stock Performance</h3>
Shares of GeneDx Hldgs were trading at $79.83 as of July 25. Over the last 52-week period, shares are up 173.95%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on GeneDx Hldgs</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding GeneDx Hldgs.
The consensus rating for GeneDx Hldgs is Buy, based on 5 analyst ratings. With an average one-year price target of $98.6, there's a potential 23.51% upside.
<h3>Comparing Ratings with Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Privia Health Gr, Addus HomeCare and Premier, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Privia Health Gr, with an average 1-year price target of $28.0, suggesting a potential 64.93% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Addus HomeCare, with an average 1-year price target of $141.5, suggesting a potential 77.25% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Premier, with an average 1-year price target of $22.67, suggesting a potential 71.6% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
In the peer analysis summary, key metrics for Privia Health Gr, Addus HomeCare and Premier are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>GeneDx Holdings</td>
<td>Buy</td>
<td>39.56%</td>
<td>$58.48M</td>
<td>-2.60%</td>
</tr>
<tr>
<td>Privia Health Gr</td>
<td>Outperform</td>
<td>15.62%</td>
<td>$45.76M</td>
<td>0.65%</td>
</tr>
<tr>
<td>Addus HomeCare</td>
<td>Outperform</td>
<td>20.29%</td>
<td>$107.68M</td>
<td>2.16%</td>
</tr>
<tr>
<td>Premier</td>
<td>Neutral</td>
<td>-8.88%</td>
<td>$193.17M</td>
<td>1.67%</td>
</tr>
</tbody>
</table>

Key Takeaway:
GeneDx Hldgs ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit. However, it is at the top for Return on Equity.
<h3>Discovering GeneDx Hldgs: A Closer Look</h3>
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
<h3>Unraveling the Financial Story of GeneDx Hldgs</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining GeneDx Hldgs's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 39.56% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: GeneDx Hldgs's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -7.49%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -2.6%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): GeneDx Hldgs's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.51%, the company may face hurdles in achieving optimal financial performance.
Debt Management: GeneDx Hldgs's debt-to-equity ratio is below the industry average. With a ratio of 0.45, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/WGS/earnings">To track all earnings releases for GeneDx Hldgs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Exploring GeneDx Hldgs's Earnings Expectations

Sensata Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-07-29. Here's what investors need to know before the announcement.
Analysts estimate that Sensata Technologies will report an earnings per share (EPS) of $0.84. 
The announcement from Sensata Technologies is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Overview of Past Earnings</h3>
The company's EPS beat by $0.02 in the last quarter, leading to a 13.76% increase in the share price on the following day.
Here's a look at Sensata Technologies's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.76</td>
<td>0.75</td>
<td>0.85</td>
<td>0.92</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.78</td>
<td>0.76</td>
<td>0.86</td>
<td>0.93</td>
</tr>
<tr>
<td>Price Change %</td>
<td>14.000000000000002%</td>
<td>9.0%</td>
<td>-6.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753725776_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Sensata Technologies were trading at $32.75 as of July 25. Over the last 52-week period, shares are down 14.12%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ST/earnings">To track all earnings releases for Sensata Technologies visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sensata Technologies's Earnings: A Preview

PJT Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>) will release its quarterly earnings report on Tuesday, 2025-07-29. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate PJT Partners to report an earnings per share (EPS) of $1.40.
The market awaits PJT Partners's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.04, leading to a 0.18% increase in the share price the following trading session.
Here's a look at PJT Partners's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.01</td>
<td>1.16</td>
<td>0.91</td>
<td>0.69</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.05</td>
<td>1.90</td>
<td>0.93</td>
<td>1.19</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753725769_0.png" alt="eps graph" />
<h3>Market Performance of PJT Partners's Stock</h3>
Shares of PJT Partners were trading at $184.1 as of July 25. Over the last 52-week period, shares are up 39.56%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on PJT Partners</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on PJT Partners.
Analysts have given PJT Partners a total of 2 ratings, with the consensus rating being Neutral. The average one-year price target is $180.0, indicating a potential 2.23% downside.
<h3>Comparing Ratings with Competitors</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Lazard, Virtu Finl and Etoro Group, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Lazard, with an average 1-year price target of $51.25, suggesting a potential 72.16% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Virtu Finl, with an average 1-year price target of $42.0, suggesting a potential 77.19% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Etoro Group, with an average 1-year price target of $75.19, suggesting a potential 59.16% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for Lazard, Virtu Finl and Etoro Group, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>PJT Partners</td>
<td>Neutral</td>
<td>-1.48%</td>
<td>$103.39M</td>
<td>32.17%</td>
</tr>
<tr>
<td>Lazard</td>
<td>Neutral</td>
<td>24.28%</td>
<td>$227.23M</td>
<td>8.23%</td>
</tr>
<tr>
<td>Virtu Finl</td>
<td>Neutral</td>
<td>30.34%</td>
<td>$496.64M</td>
<td>7.28%</td>
</tr>
<tr>
<td>Etoro Group</td>
<td>Neutral</td>
<td>10.98%</td>
<td>$222.36M</td>
<td>6.94%</td>
</tr>
</tbody>
</table>

Key Takeaway:
PJT Partners ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. PJT Partners is at the top for Return on Equity.
<h3>All You Need to Know About PJT Partners</h3>
PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.
<h3>PJT Partners: Delving into Financials</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: PJT Partners's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -1.48%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: PJT Partners's net margin is impressive, surpassing industry averages. With a net margin of 16.64%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): PJT Partners's ROE excels beyond industry benchmarks, reaching 32.17%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): PJT Partners's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.56% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.76, caution is advised due to increased financial risk.
<a href="https://www.benzinga.com/quote/PJT/earnings">To track all earnings releases for PJT Partners visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What to Expect from PJT Partners's Earnings

NMI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMIH#NASDAQ">NMIH</a>) is preparing to release its quarterly earnings on Tuesday, 2025-07-29. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect NMI Holdings to report an earnings per share (EPS) of $1.18.
The market awaits NMI Holdings's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.16, leading to a 7.52% increase in the share price the following trading session.
Here's a look at NMI Holdings's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.12</td>
<td>1.12</td>
<td>1.14</td>
<td>1.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.28</td>
<td>1.07</td>
<td>1.15</td>
<td>1.20</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.0%</td>
<td>-5.0%</td>
<td>-5.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753725760_0.png" alt="eps graph" />
<h3>Market Performance of NMI Holdings's Stock</h3>
Shares of NMI Holdings were trading at $38.07 as of July 25. Over the last 52-week period, shares are down 4.08%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analyst Insights on NMI Holdings</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on NMI Holdings.
With 4 analyst ratings, NMI Holdings has a consensus rating of Neutral. The average one-year price target is $41.5, indicating a potential 9.01% upside.
<h3>Understanding Analyst Ratings Among Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of and Onity Group, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Onity Group, with an average 1-year price target of $52.5, suggesting a potential 37.9% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary outlines pivotal metrics for and Onity Group, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>PennyMac Financial Servs</td>
<td>Outperform</td>
<td>-12.93%</td>
<td>$687.05M</td>
<td>3.44%</td>
</tr>
<tr>
<td>Onity Group</td>
<td>Buy</td>
<td>7.56%</td>
<td>$138.60M</td>
<td>4.67%</td>
</tr>
</tbody>
</table>

Key Takeaway:
NMI Holdings ranks higher than its peers in terms of revenue growth and gross profit, indicating stronger financial performance in these areas. However, it lags behind in terms of return on equity. Overall, NMI Holdings is positioned in the middle compared to its peers based on the provided metrics.
<h3>Discovering NMI Holdings: A Closer Look</h3>
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
<h3>Understanding the Numbers: NMI Holdings's Finances</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining NMI Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.88% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: NMI Holdings's net margin excels beyond industry benchmarks, reaching 59.2%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.52%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): NMI Holdings's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.01% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: NMI Holdings's debt-to-equity ratio is below the industry average at 0.18, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/NMIH/earnings">To track all earnings releases for NMI Holdings visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NMIH

A Look at NMI Holdings's Upcoming Earnings Report

DA Davidson analyst Gary Tenner maintains SouthState (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>) with a Buy and raises the price target from $115 to $117.

DA Davidson Maintains Buy on SouthState, Raises Price Target to $117

First Interstate BancSys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIBK#NASDAQ">FIBK</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-07-29. Here's a quick overview of what investors should know before the release.
Analysts are estimating that First Interstate BancSys will report an earnings per share (EPS) of $0.57.
The announcement from First Interstate BancSys is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
The company's EPS missed by $0.07 in the last quarter, leading to a 5.74% drop in the share price on the following day.
Here's a look at First Interstate BancSys's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.56</td>
<td>0.46</td>
<td>0.58</td>
<td>0.55</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.49</td>
<td>0.50</td>
<td>0.54</td>
<td>0.58</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>2.0%</td>
<td>-3.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753725748_0.png" alt="eps graph" />
<h3>Performance of First Interstate BancSys Shares</h3>
Shares of First Interstate BancSys were trading at $29.73 as of July 25. Over the last 52-week period, shares are down 6.83%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/FIBK/earnings">To track all earnings releases for First Interstate BancSys visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Nvni Group

Notizie

Ultime notizie per Nvni Group (NASDAQ:NVNI) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO